Individualized homeopathic medicines in the treatment of premenstrual syndrome: A double-blind, randomized, placebo-controlled trial

被引:0
|
作者
Sahoo, Sanjib [1 ]
Nayak, Chintamani [1 ]
Rath, Prasanta [2 ]
Bhattacharya, Soumya [3 ]
Mukherjee, Suranjana [3 ]
Dutta, Abhijit [4 ]
机构
[1] Natl Inst Homoeopathy, Dept Homoeopath Mat Med, Kolkata, India
[2] Natl Inst Homoeopathy, Dept Community Med, Kolkata, India
[3] Natl Inst Homoeopathy, Dept Homoeopath Pharm, Kolkata, India
[4] Minist Ayush Govt India, Int Cooperat Sect, New Delhi, India
关键词
Premenstrual syndrome; Homeopathy; Randomized controlled trial; Placebo; SPAF; PMTS; DYSPHORIC DISORDER;
D O I
10.1016/j.explore.2024.103039
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Introduction: Background: Premenstrual syndrome (PMS) is a common disorder among female population that adversely affects their physical and emotional well-being. Conventional treatments for PMS may have limitations and side effects, prompting a need for complementary therapeutic approaches. This double-blind, randomized, placebo-controlled trial aimed to investigate the efficacy of individualized Homeopathic medicines (IH) in treating PMS symptoms in comparison to placebo (PL). Methods: This study recruited female participants of reproductive age who had been experiencing premenstrual syndrome (PMS) for >3 months, from the Outpatient Department. The participants were randomly assigned to receive either IH or PL. The measured outcomes included the Shortened Premenstrual Assessment Form (SPAF) questionnaire as the primary outcome, and the Premenstrual Tension Syndrome Visual Analogue Scale (PMTS-VAS) and the Premenstrual Tension Syndrome Observer Rating Scale - Revised (PMTS-OR) as secondary outcomes. These measures were assessed at baseline and every month for 3 months. Results: The results showed a statistically significant reduction in total SPAF scores for the IH group compared to the placebo group (F = 11.340; P < 0.001) at month 2 (-5.5 +/- 1.8, P = 0.003), and month 3 (-6.6 +/- 2.0, P = 0.002). Additionally, there were significant reductions in PMTS-VAS and PMTS-OR scores in the IH compared to placebo group. Natrum muriaticum (n = 4/30, 13.3 %) was the most frequently indicated medicines in the study. Four adverse events (13.33 %) occurred in the IH group, and six adverse events (16.67 %) in the Placebo group, with no serious events reported, and no additional medicinal treatment was required for participants during the study period. Conclusions: Individualized Homeopathic medicines were found to be significantly effective, compared to placebo in reducing PMS symptoms. Further independent replication is warranted to validate and corroborate these findings, as well as to identify the most effective Homeopathic medicines for treating PMS symptoms. Until then, clinicians may consider these findings when exploring personalized and holistic therapeutic strategies for managing PMS.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Efficacy of Individualized Homeopathic Medicines in the Treatment of Menopausal Syndrome: Double-Blind, Randomized, Placebo-Controlled Trial
    Ghosh, Shubhamoy
    Palanisamy, Chithra
    Das, Aakash Deep
    Mandal, Sanjukta
    Guha, Nilanjana
    Maiti, Shukdeb
    Ghosh, Priyanka
    Singh, Navin Kumar
    Koley, Munmun
    Saha, Subhranil
    [J]. JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2023, 29 (10): : 649 - 664
  • [2] Individualized Homeopathic Medicines in the Treatment of Tinea Corporis: Double-Blind, Randomized, Placebo-Controlled Trial
    Laskar, Bakibillah
    Paul, Swapan
    Chattopadhyay, Abhijit
    Karuppusamy, Avaranjika
    Balamurugan, Dharshna
    Bhakta, Puja
    Das, Sourav
    Pal, Siddhartha
    Singh, Navin Kumar
    Koley, Munmun
    Saha, Subhranil
    [J]. HOMEOPATHY, 2023, 112 (02) : 74 - 84
  • [3] Individualized Homeopathic Medicines in the Treatment of Psoriasis Vulgaris: Double-Blind, Randomized, Placebo-Controlled Trial
    Balamurugan, Dharshna
    Nayak, Chintamani
    Chattopadhyay, Abhijit
    Karuppusamy, Avaranjika
    Ambrose, Maria Malathi
    Kumar, Ashwani
    Singh, Navin Kumar
    Koley, Munmun
    Saha, Subhranil
    [J]. COMPLEMENTARY MEDICINE RESEARCH, 2023, 30 (04) : 317 - 331
  • [4] Individualized Homeopathic Medicines in Treatment of Vitiligo: Double-Blind, Randomized, Placebo-Controlled Pilot Trial
    Karuppusamy, Avaranjika
    Paul, Swapan
    Chattopadhyay, Abhijit
    Balamurugan, Dharshna
    Malathi, Maria
    Kumar, Ashwani
    Suchiang, Eiphrangdaka Lyngdoh
    Sadhukhan, Satarupa
    Koley, Munmun
    Saha, Subhranil
    [J]. JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2022, 28 (01): : 96 - 102
  • [5] Efficacy of Individualized Homeopathic Medicines in the Treatment of Hemorrhoids: Double-Blind, Randomized, Placebo-Controlled Trial
    Koley, Munmun
    Vimal, Vinod Kumar
    Verma, Arvind Kumar
    Pal, Shiv Shanker
    Sonkar, Dileep Kumar
    Vimal, Smita
    Singh, Om Prakash
    Ghosh, Shubhamoy
    Saha, Subhranil
    [J]. JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2024, 30 (08): : 783 - 792
  • [6] Individualized Homeopathic Medicines in Treatment of Hyperuricemia: Evaluation by Double-Blind, Randomized, Placebo-Controlled Trial
    Ghosh, Priyanka
    Ganguly, Subhasish
    Mukherjee, Shyamal Kumar
    Dutta, Souvik
    Shaikh, Abdur Rahaman
    Ali, Sk Swaif
    Singh, Navin Kumar
    Bhattacharya, Pulakendu
    Koley, Munmun
    Saha, Subhranil
    [J]. HOMEOPATHY, 2023, 112 (02) : 85 - 96
  • [7] Individualized Homeopathic Medicines in Chronic Rhinosinusitis: Randomized, Double-Blind, Placebo-Controlled Trial
    Misra, Pankhuri
    Nayak, Chintamani
    Chattopadhyay, Abhijit
    Palit, Tarun Kumar
    Gupta, Bharti
    Sadhukhan, Satarupa
    Bhar, Koushik
    Rai, Shruti
    Parewa, Maneet
    Ali, Sk Swaif
    Basu, Anamika
    Nath, Arunava
    Koley, Munmun
    Saha, Subhranil
    [J]. HOMEOPATHY, 2021, 110 (01) : 13 - 26
  • [8] Efficacy of individualized homeopathic medicines in irritable bowel syndrome: A double-blind randomized, placebo-controlled trial
    Das, Aakash Deep
    Ghosh, Shubhamoy
    Palanisamy, Chithra
    Guha, Nilanjana
    Mandal, Sanjukta
    Maiti, Shukdeb
    Nath, Arunava
    Singh, Navin Kumar
    Koley, Munmun
    Saha, Subhranil
    [J]. EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2023, 19 (04) : 519 - 527
  • [9] Efficacy of individualized homeopathic medicines in treatment of cervical spondylosis: Double-blind, randomized, placebo-controlled trial
    Tomar, Maneela
    Bhowmik, Nitai Chand
    Singh, Subhas
    Sadhukhan, Satarupa
    Michael, James
    Parewa, Maneet
    Rai, Shruti
    Gupta, Bharti
    Vashisht, Himani
    Misra, Pankhuri
    Koley, Munmun
    Saha, Subhranil
    [J]. COMPLEMENTARY MEDICINE RESEARCH, 2023, 30 (01) : 26 - 36
  • [10] Individualized Homeopathic Medicines in the Treatment of Knee Osteoarthritis: Double-Blind, Randomized, Placebo-Controlled Feasibility Trial
    Bhattacharyya, Soumya
    Chatterjee, Chandrima
    Saha, Subhranil
    Naskar, Satyajit
    Bhattacharya, Pulakendu
    Alam, Sk Monsur
    Sengupta, Sumana
    Ahamed, Sabir
    Shaikh, Abdur R.
    Koley, Munmun
    Ghosh, Priyanka
    Mukherjee, Shyamal K.
    [J]. HOMEOPATHY, 2024, 113 (03) : 158 - 166